Amexdrug Corporation

Total Valuation

Amexdrug Corporation carries a market capitalization of 33,882.00, placing it among publicly traded companies globally. Its enterprise value stands at 26.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Amexdrug Corporation currently has 169.11M shares outstanding.

Valuation Ratios

Amexdrug Corporation trades at a trailing price-to-earnings ratio of 153.23. The price-to-sales ratio is 2.77, and the price-to-book ratio stands at 33.77.

Enterprise Valuation

On an enterprise value basis, Amexdrug Corporation trades at an EV/EBITDA multiple of 68.53 and an EV/FCF ratio of 63.06. The EV/Sales ratio of 2.85 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 78.86 provides insight into valuation relative to core operating earnings.

Financial Position

Amexdrug Corporation maintains a current ratio of 1.35, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 129.60, indicating elevated leverage, while an interest coverage ratio of 7.98 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Amexdrug Corporation posts a return on equity of 28.16 and a return on invested capital of 14.81.

Taxes

Over the trailing twelve months, Amexdrug Corporation has paid 120,226.00 in income taxes, reflecting an effective tax rate of 42.03.

Stock Price Statistics

Amexdrug Corporation's stock has declined approximately -90% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Income Statement

Over the trailing twelve months, Amexdrug Corporation generated 9.17M in revenue and converted that into 165,837.00 in net income, yielding earnings per share of 0.00. EBITDA reached 380,825.00, while operating income came in at 330,931.00.

Balance Sheet

Amexdrug Corporation holds 168,009.00 in cash and equivalents against 853,092.00 in total debt, resulting in a net debt position of 690,527.00. Total book value stands at 752,395.00, with working capital of 456,846.00 providing operational flexibility.

Cash Flow

Amexdrug Corporation produced -74,833.00 in operating cash flow over the past twelve months. After subtracting -460,984.00 in capital expenditures, free cash flow totaled -535,817.00 - equivalent to 0.00 per share.

Margins

Amexdrug Corporation operates with a gross margin of 13.76, reflecting its pricing power and cost economics. The operating margin of 3.61 and net profit margin of 1.81 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Amexdrug Corporation's most recent stock split took place on December 3, 2012 with a 1:20 split ratio.

Scores

Amexdrug Corporation posts an Altman Z-Score of 14.50, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.